Rami A. Alzahrani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rami A. Alzahrani has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Imadeddin Malek
Mohammad Bin Rashid University of Medicine and Health Sciences, Dubai Health
1 shared publication - Ahmed S. Alzahrani
Imam Abdulrahman Bin Faisal University
1 shared publication Ali A. Alqarni
Faculty of Medicine, King AbdulAziz University, Jeddah, Kingdom of Saudi Arabia
1 shared publication- Bander Fahad Aljarallah
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia
1 shared publication - Faris H. Hejazi
King Khalid University
1 shared publication Fatmah A. Alenezi
Kuwait University
1 shared publication
Latest Publications
- Open Access
- 7 May 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Systemic Corticosteroids versus Intratympanic Corticosteroids as Primary Treatments for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis
Objectives: Idiopathic sudden sensorineural hearing loss (ISSNHL) is a rapidly progressive disease that may cause permanent hearing loss. Standard primary treatments include oral corticosteroids (OCs) or intratympanic corticosteroids (ITCs). This study aimed to evaluate the effectiveness and safety of OCs versus ITCs as primary treatments for ISSNHL. Design: This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched Medline, Google Scholar, Web of Science, Embase, and Scopus, identifying 11 RCTs comprising 833 patients. Results: Both OCs and ITCs significantly improved hearing, with average pure tone audiometry (PTA) gains ranging from 12 to 40 dB. No significant between-intervention difference was observed in post-treatment PTA. Generally, combination therapy yielded the greatest improvements (>40 dB and >60% recovery). OCs caused systemic adverse effects, whereas ITCs produced mostly mild local effects. Conclusions: Both treatment routes effectively improved hearing in patients with ISSNHL, with neither demonstrating clear superiority in overall efficacy. However, combination therapy may be associated with better hearing outcomes.
- 7 May 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessSystemic Corticosteroids versus Intratympanic Corticosteroids as Primary Treatments for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis
Objectives: Idiopathic sudden sensorineural hearing loss (ISSNHL) is a rapidly progressive disease that may cause permanent hearing loss. Standard primary treatments include oral corticosteroids (OCs) or intratympanic corticosteroids (ITCs). This study aimed to evaluate the effectiveness and safety of OCs versus ITCs as primary treatments for ISSNHL. Design: This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched Medline, Google Scholar, Web of Science, Embase, and Scopus, identifying 11 RCTs comprising 833 patients. Results: Both OCs and ITCs significantly improved hearing, with average pure tone audiometry (PTA) gains ranging from 12 to 40 dB. No significant between-intervention difference was observed in post-treatment PTA. Generally, combination therapy yielded the greatest improvements (>40 dB and >60% recovery). OCs caused systemic adverse effects, whereas ITCs produced mostly mild local effects. Conclusions: Both treatment routes effectively improved hearing in patients with ISSNHL, with neither demonstrating clear superiority in overall efficacy. However, combination therapy may be associated with better hearing outcomes.
- 18 June 2023
- Published by Elsevier in Journal of Tissue Viability
- Vol. 32 (3) , 417-422
The effect of therapeutic footwear on the recurrence and new formation of foot ulcers in previously affected diabetic patients in Jeddah, Saudi Arabia
- 18 June 2023
- Published by Elsevier in Journal of Tissue Viability
- Vol. 32 (3) , 417-422
The effect of therapeutic footwear on the recurrence and new formation of foot ulcers in previously affected diabetic patients in Jeddah, Saudi Arabia